Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 30, 2014Genome AnnouncementsOpen Access

Genome Sequence of Bacillus amyloliquefaciens GB03, an Active Ingredient of the First Commercial Biological Control Product

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSoo-Keun ChoiHJHaeyoung JeongJKJoseph W. Kloepper

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Choi et al. (2014) studied this question.

synapsesocial.com/papers/6a97d0e8a2c7923eae15dec4https://doi.org/10.1128/genomea.01092-14
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Shifting the genomic gold standard for the prokaryotic species definition2009 · 6,525 citations
  2. 2The RAST Server: Rapid Annotations using Subsystems Technology2008 · 12,084 citations
  3. 3Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB422007 · 889 citations
  4. 4Ecology of <i>Bacillus</i> and <i>Paenibacillus</i> spp. in Agricultural Systems2004 · 321 citations
  5. 5Induced Systemic Resistance and Promotion of Plant Growth by <i>Bacillus</i> spp.2004 · 1,687 citations